IIB 
117TH CONGRESS 
1ST SESSION H. R. 1899 
IN THE SENATE OF THE UNITED STATES 
APRIL 19, 2021 
Received; read twice and referred to the Committee on the Judiciary 
AN ACT 
To amend the Controlled Substances Act to provide for the 
modification, transfer, and termination of a registration 
to manufacture, distribute, or dispense controlled sub-
stances or list I chemicals, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:15 Apr 20, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H1899.RFS
H1899
pamtmann on DSKBC07HB2PROD with BILLS
HR 1899 RFS
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Ensuring Compliance 
Against Drug Diversion Act of 2021’’. 
SEC. 2. MODIFICATION, TRANSFER, AND TERMINATION OF 
REGISTRATION 
TO 
MANUFACTURE, 
DIS-
TRIBUTE, OR DISPENSE CONTROLLED SUB-
STANCES. 
Subsection (a) of section 302 of the Controlled Sub-
stances Act (21 U.S.C. 822) is amended by adding at the 
end the following new paragraph: 
‘‘(3)(A) Except as provided in subparagraph (C), the 
registration of any registrant under this title to manufac-
ture, distribute, or dispense controlled substances or list 
I chemicals terminates if and when such registrant— 
‘‘(i) dies; 
‘‘(ii) ceases legal existence; 
‘‘(iii) discontinues business or professional prac-
tice; or 
‘‘(iv) surrenders such registration. 
‘‘(B) In the case of such a registrant who ceases legal 
existence or discontinues business or professional practice, 
such registrant shall promptly notify the Attorney General 
in writing of such fact. 
‘‘(C) No registration under this title to manufacture, 
distribute, or dispense controlled substances or list I 
chemicals, and no authority conferred thereby, may be as-
VerDate Sep 11 2014 
00:15 Apr 20, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H1899.RFS
H1899
pamtmann on DSKBC07HB2PROD with BILLS
HR 1899 RFS
signed or otherwise transferred except upon such condi-
tions as the Attorney General may specify and then only 
pursuant to written consent. A registrant to whom a reg-
istration is assigned or transferred pursuant to the pre-
ceding sentence may not manufacture, distribute, or dis-
pense controlled substances or list I chemicals pursuant 
to such registration until the Attorney General receives 
such written consent. 
‘‘(D) In the case of a registrant under this title to 
manufacture, distribute, or dispense controlled substances 
or list I chemicals desiring to discontinue business or pro-
fessional practice altogether or with respect to controlled 
substances and list I chemicals (without assigning or 
transferring such business or professional practice to an-
other entity), such registrant shall return to the Attorney 
General for cancellation— 
‘‘(i) the registrant’s certificate of registration; 
‘‘(ii) any unexecuted order forms in the reg-
istrant’s possession; and 
‘‘(iii) any other documentation that the Attor-
ney General may require.’’. 
SEC. 3. DETERMINATION OF BUDGETARY EFFECTS. 
The budgetary effects of this Act, for the purpose of 
complying with the Statutory Pay-As-You-Go Act of 2010, 
shall be determined by reference to the latest statement 
VerDate Sep 11 2014 
00:15 Apr 20, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H1899.RFS
H1899
pamtmann on DSKBC07HB2PROD with BILLS
HR 1899 RFS
titled ‘‘Budgetary Effects of PAYGO Legislation’’ for this 
Act, submitted for printing in the Congressional Record 
by the Chairman of the House Budget Committee, pro-
vided that such statement has been submitted prior to the 
vote on passage. 
Passed the House of Representatives April 15, 2021. 
Attest: 
CHERYL L. JOHNSON, 
Clerk. 
VerDate Sep 11 2014 
00:15 Apr 20, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H1899.RFS
H1899
pamtmann on DSKBC07HB2PROD with BILLS